Top Markets
Coin of the day
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
株式のランク #13820
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
株価
$12.63
時価総額
$458.19M
変化(1日)
-3.26%
変化(1年)
-
US
取引 Evommune, Inc. (EVMN)

カテゴリー

Evommune, Inc.(EVMN)の株価履歴
終値の最高値: $13.94 (2026-08-01)

終値の最安値: $19.25 (2025-11-01)
Evommune, Inc. の株価履歴(2025 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 9.44%
2025 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.01 -13.08%
AU
$138.80 476.17%
US
$749.90 5.87%
CH